“I am pleased to have the opportunity to ensure that in every major decision the organization makes, the needs of patients and care givers will be considered. As the parent of children with a rare disease and co-founder and president of a foundation dedicated to medical research, I recognize the importance and, above all, the urgency of accessing new innovative medical therapies” mentioned Me Jean Groleau during his appointment to the board of directors of Catalis.

Launched in 2017, CATALIS’ mandate is, among other things, to facilitate collaboration between the various actors and to accelerate the development of innovative treatments.